IPO Year: 2021
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/1/2021 | $16.00 | Buy | Roth Capital |
| 10/6/2021 | $15.00 | Buy | Maxim Group |
4 - RenovoRx, Inc. (0001574094) (Issuer)
4 - RenovoRx, Inc. (0001574094) (Issuer)
4 - RenovoRx, Inc. (0001574094) (Issuer)
4 - RenovoRx, Inc. (0001574094) (Issuer)
4 - RenovoRx, Inc. (0001574094) (Issuer)
4 - RenovoRx, Inc. (0001574094) (Issuer)
4 - RenovoRx, Inc. (0001574094) (Issuer)
4 - RenovoRx, Inc. (0001574094) (Issuer)
4 - RenovoRx, Inc. (0001574094) (Issuer)
4 - RenovoRx, Inc. (0001574094) (Issuer)
Roth Capital initiated coverage of RenovoRx with a rating of Buy and set a new price target of $16.00
Maxim Group initiated coverage of RenovoRx with a rating of Buy and set a new price target of $15.00
10-Q - RenovoRx, Inc. (0001574094) (Filer)
8-K - RenovoRx, Inc. (0001574094) (Filer)
SCHEDULE 13G - RenovoRx, Inc. (0001574094) (Subject)
SCHEDULE 13G - RenovoRx, Inc. (0001574094) (Subject)
DEF 14A - RenovoRx, Inc. (0001574094) (Filer)
8-K - RenovoRx, Inc. (0001574094) (Filer)
10-K - RenovoRx, Inc. (0001574094) (Filer)
NT 10-K - RenovoRx, Inc. (0001574094) (Filer)
8-K - RenovoRx, Inc. (0001574094) (Filer)
424B5 - RenovoRx, Inc. (0001574094) (Filer)